Halozyme Therapeutics, Inc.

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

733,562

Value ($000)

49,369

Weight

0.0%

2013 Q4 - 2025 Q4 (27 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	49,369	0.0%	733,562	12/31/2025
2025 Q3	11/14/2025	23,980	0.0%	326,967	9/30/2025
2025 Q2	8/14/2025	25,820	0.0%	496,344	6/30/2025
2025 Q1	5/19/2025	26,562	0.0%	416,262	3/31/2025
2024 Q4	2/14/2025	18,640	0.0%	389,875	12/31/2024
2024 Q3	11/14/2024	22,772	0.0%	397,833	9/30/2024
2024 Q2	8/14/2024	22,621	0.0%	432,024	6/30/2024
2024 Q1	5/15/2024	6,548	0.0%	160,954	3/31/2024
2023 Q4	2/14/2024	5,957	0.0%	161,180	12/31/2023
2023 Q3	11/13/2023	6,018	0.0%	157,537	9/30/2023
2023 Q2	8/11/2023	12,779	0.0%	334,608	6/30/2023
2023 Q1	5/15/2023	12,779	0.0%	334,608	3/31/2023
2022 Q4	2/14/2023	29,501	0.0%	518,479	12/31/2022
2022 Q3	11/14/2022	20,559	0.0%	519,951	9/30/2022
2022 Q2	8/12/2022	7,782	0.0%	176,864	6/30/2022
2022 Q1	5/16/2022	6,679	0.0%	167,465	3/31/2022
2021 Q4	2/14/2022	6,066	0.0%	150,868	12/31/2021
2021 Q3	11/15/2021	6,010	0.0%	147,738	9/30/2021
2021 Q2	8/16/2021	7,052	0.0%	155,295	6/30/2021
2021 Q1	5/14/2021	6,299	0.0%	151,102	3/31/2021
2020 Q4	3/1/2021	6,585	0.0%	154,177	12/31/2020
2020 Q3	11/13/2020	3,711	0.0%	141,200	9/30/2020
2020 Q2	8/14/2020	3,898	0.0%	145,392	6/30/2020
2020 Q1	5/15/2020	15,709	0.0%	873,192	3/31/2020
2019 Q4	2/14/2020	18,764	0.0%	1,058,329	12/31/2019
2014 Q1	5/23/2014	432	0.0%	33,996	3/31/2014
2013 Q4	1/31/2014	510	0.0%	33,996	12/31/2013